Draayer D - Search Results

Year	Number of Results
1973	2
1974	3
1975	1
1976	2
1977	6
1978	6
1979	3
1980	6
1981	4
1982	4
1983	4
1984	8
1985	2
1986	3
1987	4
1988	7
1993	1
2003	2
2004	2
2018	1
2019	1
2021	1
2022	1
2024	0

1

Overview of the 2017 KDIGO CKD-MBD Update: Practice Implications for Adult Hemodialysis Patients.

Beto J, Bhatt N, Gerbeling T, Patel C, Drayer D. Beto J, et al. Among authors: drayer d. J Ren Nutr. 2019 Jan;29(1):2-15. doi: 10.1053/j.jrn.2018.05.006. Epub 2018 Aug 24. J Ren Nutr. 2019. PMID: 30150095 Free article. Review.

2

Effects of renal disease upon drug disposition.

Reidenberg MM, Drayer DE. Reidenberg MM, et al. Among authors: drayer de. Drug Metab Rev. 1978;8(2):293-302. doi: 10.3109/03602537808993789. Drug Metab Rev. 1978. PMID: 363386 Review. No abstract available.

3

Drug therapy in renal failure.

Reidenberg MM, Drayer DE. Reidenberg MM, et al. Among authors: drayer de. Annu Rev Pharmacol Toxicol. 1980;20:45-54. doi: 10.1146/annurev.pa.20.040180.000401. Annu Rev Pharmacol Toxicol. 1980. PMID: 6992702 Review. No abstract available.

4

Clinical consequences of the lipophilicity and plasma protein binding of antiarrhythmic drugs and active metabolites in man.

Drayer DE. Drayer DE. Ann N Y Acad Sci. 1984;432:45-56. doi: 10.1111/j.1749-6632.1984.tb14507.x. Ann N Y Acad Sci. 1984. PMID: 6151820 Review.

5

Hydralazine elimination in man.

Reidenberg MM, Drayer D, DeMarco AL, Bello CT. Reidenberg MM, et al. Among authors: drayer d. Clin Pharmacol Ther. 1973 Nov-Dec;14(6):970-7. doi: 10.1002/cpt1973146970. Clin Pharmacol Ther. 1973. PMID: 4584155 Clinical Trial. No abstract available.

6

Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia.

Goodman WG, Ward DT, Martin KJ, Drayer D, Moore C, Xu J, Lai J, Chon Y, Nemeth EF. Goodman WG, et al. Among authors: drayer d. J Am Soc Nephrol. 2022 Jan;33(1):201-212. doi: 10.1681/ASN.2021060825. Epub 2021 Nov 3. J Am Soc Nephrol. 2022. PMID: 34732508 Free PMC article.

7

Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Drayer DE. Drayer DE. Clin Pharmacokinet. 1976 Nov-Dec;1(6):426-43. doi: 10.2165/00003088-197601060-00003. Clin Pharmacokinet. 1976. PMID: 799549 Review.

8

Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers.

Drayer DE. Drayer DE. Pharmacotherapy. 1987;7(4):87-91. doi: 10.1002/j.1875-9114.1987.tb04029.x. Pharmacotherapy. 1987. PMID: 2891122 Review.

9

Active drug metabolites and renal failure.

Drayer DE. Drayer DE. Am J Med. 1977 Apr;62(4):486-9. doi: 10.1016/0002-9343(77)90402-8. Am J Med. 1977. PMID: 851118

10

Propylthiouracil-induced immune-mediated disease in the cat.

Aucoin DP, Peterson ME, Hurvitz AI, Drayer DE, Lahita RG, Quimby FW, Reidenberg MM. Aucoin DP, et al. Among authors: drayer de. J Pharmacol Exp Ther. 1985 Jul;234(1):13-8. J Pharmacol Exp Ther. 1985. PMID: 3874279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year